ArticleTrials2020

Prophylactic prednisolone for the prevention of early and intermediate adverse effects of radioactive iodine therapy in patients with thyroid cancer: study protocol for a single-centre, phase II/III, randomized, double-blinded, placebo-controlled clinical trial.

Umesh Jayarajah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.